ЖАНРЫ

Респираторная медицина. Руководство (в 2-х томах)
Шрифт:

33.Lerer I, Cohen S, Chemke M,et al.. The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs.//Hum Genet. 1990 Sep;85(4):416-7.

34.Watson EK, Mayall ES, Simova L, et al. The incidence of delta F508 CF mutation, and associated haplotypes, in a sample of English CF families. //Hum Genet. 1990 Sep;85(4):435-6

35.Koch C, Cuppens H, Rainisio M, et al.. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations.//Pediatr Pulmonol. 2001 Jan;31(1):1-12.

36.Капранов Н.И., Шабалова Л.А., Каширская Н.Ю. и др. Муковисцидоз (современные достижения и проблемы). Методические рекомендации. М.: Медпрактика 2005. С.76

37.Dulhanty AM, Chang XB, Riordan JR., Mutation of potential phosphorylation sites in the recombinant R domain of the cystic fibrosis transmembrane conductance regulator has significant effects on domain conformation.//Biochem Biophys Res Commun. 1995 Jan 5;206(1):207-14.

38.Chang XB, Hou YX, Jensen TJ, Riordan JR., Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion.//J Biol Chem. 1994 Jul 15;269(28):18572-5.

39.Davis PB., Molecular and cell biology of cystic fibrosis.//,J Appl Physiol. 1991 May;70(5):2331-3.

40.Knowles MR, Robinson JM, Wood RE, et al: Ion composition of airway surface liquid of patients with cystic fibrosis as compared to normal and disease-control subjects. //J Clin Invest 100:2588-2595, 1997.

41.Berger HA, Travis SM, Welsh MJ: Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by specific protein kinases and protein phosphatases.// J Biol Chem 268:2037-2047, 1993

42.Smith J.J., Travis S.M., Greenberg E.P., Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. //Cell. 196; 85: 229-236.

43.Bonfeld T.L., Konstan M.W., Burfeind P. et al. Normal bronchial epitheliual cells constitutely produce the anti-inflammatory cytokine IL-10 which is down-regulated in cystic fibrosis.//Am. J. Resp. Cell Mol. Biol. 1995; 13: 257-261.

44.Sommerhof C.P., Nadel J.A., Basbaum C.B., Caughey G.H. Neutrophil elastase and catepsin G stimulate secretion from cultures bovine airway glands.// J. Clin. Invest. 1990; 85: 682-689.

45.Berger M., Sorensen R.U., Tosi M.F. et al. Complement receptor expression on neutrophils at the inflammatory site, The Pseudomonas-infected lung in cystic fibrosis.// J. Clin. Invest. 1989; 84: 1302-1313.

46.De Rose V. Mechanisms and markers of airway inflammation in cystiv fibrosis.//Eur. Resp. J. 2002; 19: 333-340.

47.Matsui H., Grubb B.R., Tarran R.et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. //Cell. 1998; 95: 1005-1015.

48.Guggino W.B. Cystic fibrosis and the salt conroversy. //Cell. 1999; 96: 607-610.

49.Кучкина Н.В., Самсонова М.В. Влияние осмотичности среды на морфофункциональное состояние нейтрофилов крови при муковисцидозе. //Пульмонология. 1996; 4: 77-79.

50.Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing.// J Immunol. 2005 Dec 1;175(11):7512-8

51.Ornoy A., Arnon J., Katznelson D. et al. Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis.// Am. J. Med. Genet. 1987; 28: 935-947.

52.Oppenheimer E.H., Esterly J.R. Pathology of cystic fibrosis; review of literature and comparison of 146 autopsied cases.// Perspect. Pediatr. Pathol. 1975; 2: 241-278.

53.Sheppard M.N. The pathology of cystic fibrosis. In: Cystic fibrosis./ Eds. M.E. Hodson and D.M. Geddes. Chapman & Hall Medical. London. 1997: 131-149.

54.Bedrossian C.W., Greenberg S.D., Singer D.B. et al. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups.// Hum. Pathol. 1976; 7: 195-204.

55.Tomashefski J.F., Dahms B., Bruce M. Pleura in pneumothorax. Comparison of patients with cystic fibrosis and idiopatic spontaneous pneumothorax. //Arch. Patholl. Lab. Med. 1985. 109: 910-916.

56.Зашихин А.Л., Агафонов Ю.В., Заостровская Л.А., Черняев А.Л., Быков В.П. Морфофункциональная организация гладкой мышечной ткани бронхов различных генераций у человека // Пульмонология.- 1997.- 3.- С.61-64.

57.Guidotti T.L., Luetzeker J., di Sant’Agnese P.A. et al. Fatal disseminated aspergollosis in a previously well young adult with cystic fibrosis.// Am. J. Med. Sci. 1982; 282: 157-160.

58.Bhargava V., Tomashefski J.F., Stern R.C., Abramovsky C.R. The pathology of fungal infection and colonization in patients with cystic fibrosis.// Hum. Pathol. 1989; 20: 977

59.Brueton M.J., Ormerod L.P., Shah K.J., Anderson C.M. Allergic bronchopulmonary aspergillosis cimplicating cystic fibrosis in childhood.//Arch. Dis. Child. 1980; 55: 348-353.

60.Zeaske R., Bruns W.T., Fink J.N. et al. Immune response to Aspergillus in cystic fibrosis.// J. Allergy Clin. Immunol. 1988; 82: 73-77.

61.Bosken C.H., Myers J.L., Greenberger P.A., Katzenstein A.L. Pathologic features of allergic bronchopulmonary aspergillosis.//Am. J. Surg. Pathol. 1988; 12: 216-222.

62.Boat T.F., di Sat’Agnese P., Warwick W.J., Handwerger S.A. Pneumotorax in cystic fibrosis. //J. Am. Med. Assoc. 1969. 209: 1498-1504.

63.-Fellows K.E., Stigol L., Schuster S., et al. Selective bronchila arterigraphy in patients with cystic fibrosis and massive hemoptysis.// Radiology. 1975; 114: 551-555.

64.Ryland D., Reid L. The pulmonary circulation in cystic fibrosis. //Thorax; 1975: 285-292.

65.McGlennen R.C., Burke B.A., Dehner L.P. Systemic amyloidosis complicating cystic fibrosis. //Arch. Pathol. Lab. Med. 1968; 110: 879-884.

66.Di Sant'Agnese PA, Hubbard VS: The pancreas. Cystic Fibrosis. New York: Thieme-Stratton, 1984, pp 230-295

67.Handwerger S, Roth J, Gorden P, et al: Glucose intolerance in cystic fibrosis. //N Engl J Med 281:451-461, 1969

68.Di Sant'Agnese PA, Hubbard VS: The hepatobiliary system. Cystic Fibrosis. New York: Thieme-Stratton, 1984, pp 296-322

Поделиться с друзьями: